Identification of novel drugs to target dormant micrometastases

BACKGROUND: Cancer-specific survival has changed remarkably little over the past half century, mainly because metastases that are occult at diagnosis and generally resistant to chemotherapy subsequently develop months, years or even decades following definitive therapy. Targeting the dormant microme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Hurst, Robert E., Hauser, Paul J., You, Youngjae, Bailey-Downs, Lora C., Bastian, Anja, Matthews, Stephen M., Thorpe, Jessica, Earle, Christine, Bourguignon, Lilly Y. W., Ihnat, Michael A.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4434572/
https://ncbi.nlm.nih.gov/pubmed/25971923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1409-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados